The Excellence Awards celebrate the greatest achievements and innovations in the industry. The programme provides a platform to recognize the people and companies that are driving change.
Our programme is designed to highlight excellence within the sector by looking at a range of corporate activities including deals, business projects and company initiatives, both internal and in the community.
What is Innovation?
Innovation is the category with one of the widest scopes within the Excellence Rankings as it looks at novel new approaches in every area, from the fruits of research and development to novel new business practices. What all the ranked entities have in common is the demonstration of new concepts not just within their own business but in the sector as a whole.
The category includes any projects that demonstrate an innovative approach to the market. The category crosses over with many of our other categories and can include new products, novel product features, new business practices, new marketing and sales strategies and more.
As with many other categories, AI has been a major driving force for innovation in the field of clinical trials, with companies using AI as a tool for trial optimisation, trial recruitment and trial decentralisation.
One of the newest developments during this research period has been the use of AI in the process of drug development with Excientia’s AI designed immuno-oncology molecule as one such example.
In terms of medical fields oncology and heart disease remain the most active areas when it comes to innovative developments.
Is your company listed?
If you want to learn more about the Awards and the range of marketing materials and options available to promote your achievement then please get in touch with us or download the Media Pack:
Contact: Olga Kovalova – Olga.Kovalova@globaldata.com
Book a meeting with Olga – https://calendly.com/olga-kovalova
The category highlights clinical trials companies that have shown innovative approaches in the development of drugs and treatments.